Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Atezolizumab 9 found (55 total)

alternate case: atezolizumab

Soft-tissue sarcoma (2,395 words) [view diff] exact match in snippet view article find links to article

part sarcoma has a regulatory approval for such an agent, in this case atezolizumab. When the immunological constant of rejection signature (ICR) was retrospectively
Sarcoma (3,903 words) [view diff] exact match in snippet view article find links to article
yet FDA- or other regulator-approved treatment, except PDL1 inhibitor atezolizumab for the ultra-rate diagnosis of alveolar soft part sarcoma. Other strategies
Non-small-cell lung cancer (5,301 words) [view diff] exact match in snippet view article find links to article
cells, and result in decreased tumor cell kill by the immune system. Atezolizumab is an anti PD-L1 monoclonal antibody. Nivolumab and Pembrolizumab are
Selvigaltin (264 words) [view diff] exact match in snippet view article find links to article
(1 June 2022). "GALLANT-1: Galectin-3 (Gal-3) inhibitor GB1211 plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized
Sherene Loi (852 words) [view diff] exact match in snippet view article find links to article
has over 40,000 citations in Google Scholar. P Schmid, et al. (2018) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. New England
Interstitial nephritis (2,303 words) [view diff] exact match in snippet view article find links to article
sunitinib), checkpoint inhibitors (e.g. ipilimumab, nivolumab, pembrolizumab, atezolizumab) Contrast agent Gadolininum based contrast agent Other Allopurinol, Chinese
Anaplastic thyroid cancer (2,157 words) [view diff] exact match in snippet view article find links to article
trials demonstrating promising effects. Specific drugs being tested are atezolizumab, pembrolizumab, and spartalizumab, amongst others. Combinatorial therapy
Cora Sternberg (3,310 words) [view diff] exact match in snippet view article find links to article
highest contributor to the SAUL study4, an extended access program of atezolizumab, a fully humanized, engineered monoclonal antibody of IgG1 isotype against
G1 Therapeutics (2,065 words) [view diff] exact match in snippet view article find links to article
D., et al., December 21, 2020, Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: